Madamsetty VS - Search Results

1

LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells.

Angom RS, Zhu J, Wu ATH, Sumitra MR, Pham V, Dutta S, Wang E, Madamsetty VS, Perez-Cordero GD, Huang HS, Mukhopadhyay D, Wang Y. Angom RS, et al. Among authors: madamsetty vs. J Inflamm Res. 2021 Sep 8;14:4551-4565. doi: 10.2147/JIR.S305168. eCollection 2021. J Inflamm Res. 2021. PMID: 34526801 Free PMC article.

2

Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer.

Pal K, Madamsetty VS, Dutta SK, Wang E, Angom RS, Mukhopadhyay D. Pal K, et al. Among authors: madamsetty vs. NPJ Precis Oncol. 2019 Dec 5;3:31. doi: 10.1038/s41698-019-0105-2. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 31840081 Free PMC article.

3

Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC.

Pal K, Madamsetty VS, Dutta SK, Mukhopadhyay D. Pal K, et al. Among authors: madamsetty vs. Int J Nanomedicine. 2019 Jul 11;14:5109-5123. doi: 10.2147/IJN.S204221. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31371950 Free PMC article.

4

Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme.

Angom RS, Mondal SK, Wang F, Madamsetty VS, Wang E, Dutta SK, Gulani Y, Sarabia-Estrada R, Sarkaria JN, Quiñones-Hinojosa A, Mukhopadhyay D. Angom RS, et al. Among authors: madamsetty vs. Oncogene. 2020 Nov;39(48):7114-7126. doi: 10.1038/s41388-020-01462-1. Epub 2020 Oct 1. Oncogene. 2020. PMID: 33005016

5

Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS.

Vivekanandhan S, Madamsetty VS, Angom RS, Dutta SK, Wang E, Caulfield T, Pletnev AA, Upstill-Goddard R, Asmann YW, Chang D, Spaller MR, Mukhopadhyay D. Vivekanandhan S, et al. Among authors: madamsetty vs. Cancers (Basel). 2021 Aug 11;13(16):4048. doi: 10.3390/cancers13164048. Cancers (Basel). 2021. PMID: 34439202 Free PMC article.

6

Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer.

Madamsetty VS, Pal K, Dutta SK, Wang E, Mukhopadhyay D. Madamsetty VS, et al. Cancers (Basel). 2020 May 8;12(5):1189. doi: 10.3390/cancers12051189. Cancers (Basel). 2020. PMID: 32397114 Free PMC article.

7

Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension.

Wang Y, Wang E, Zhang Y, Madamsetty VS, Ji B, Radisky DC, Grande JP, Misra S, Mukhopadhyay D. Wang Y, et al. Among authors: madamsetty vs. FASEB J. 2019 Jan;33(1):494-500. doi: 10.1096/fj.201800499R. Epub 2018 Aug 17. FASEB J. 2019. PMID: 30118322 Free PMC article.

8

Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer.

Madamsetty VS , Pal K , Keshavan S , Caulfield TR , Dutta SK , Wang E , Fadeel B , Mukhopadhyay D . Madamsetty VS , et al. Nanoscale. 2019 Nov 21;11(45):22006-22018. doi: 10.1039/c9nr05478b. Nanoscale. 2019. PMID: 31710073

9

Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response.

Ding L, Madamsetty VS, Kiers S, Alekhina O, Ugolkov A, Dube J, Zhang Y, Zhang JS, Wang E, Dutta SK, Schmitt DM, Giles FJ, Kozikowski AP, Mazar AP, Mukhopadhyay D, Billadeau DD. Ding L, et al. Among authors: madamsetty vs. Clin Cancer Res. 2019 Nov 1;25(21):6452-6462. doi: 10.1158/1078-0432.CCR-19-0799. Epub 2019 Sep 18. Clin Cancer Res. 2019. PMID: 31533931 Free PMC article.

10

Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma.

Madamsetty VS, Pal K, Dutta SK, Wang E, Thompson JR, Banerjee RK, Caulfield TR, Mody K, Yen Y, Mukhopadhyay D, Huang HS. Madamsetty VS, et al. Bioconjug Chem. 2019 Oct 16;30(10):2703-2713. doi: 10.1021/acs.bioconjchem.9b00632. Epub 2019 Oct 4. Bioconjug Chem. 2019. PMID: 31584260

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page